Related Experiment Video
Updated: Dec 24, 2025

14:40
Long-term Lethal Toxicity Test with the Crustacean Artemia franciscana
Published on: April 14, 2012
20.4K
Artemia species: An Important Tool to Screen General Toxicity Samples
Epole Ntungwe N1,2, Eva M Domínguez-Martín1,2, Amilcar Roberto1
1CBIOS - Center for Research in Biosciences & Health Technologies, Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisbon, Portugal
Current Pharmaceutical Design
|April 7, 2020
Summary
Medicinal plants yield novel drugs from phytochemicals. The brine shrimp lethality assay (BSLA) offers a rapid, cost-effective method for screening plant extracts to discover bioactive natural products.
Area of Science:
- Marine Biology
- Ecotoxicology
- Natural Product Chemistry
Background:
- Medicinal plants are rich sources of novel therapeutic compounds.
- Artemia (brine shrimp) are vital in marine ecosystems and used in various scientific fields.
- The brine shrimp lethality assay (BSLA) is a widely adopted preliminary toxicity test.
Purpose of the Study:
- To review and consolidate knowledge on Artemia salina's applications.
- To highlight Artemia as a bench-top bioassay for natural product discovery.
- To discuss its role in purifying bioactive compounds from medicinal plants.
Main Methods:
- Literature review and synthesis of existing research on Artemia applications.
- Focus on the brine shrimp lethality assay (BSLA) in natural product screening.
- Analysis of Artemia's utility in drug discovery from medicinal plants.
Main Results:
- Artemia is a versatile tool in ecotoxicology, aquaculture, and genetics.
- The BSLA is a valuable, low-cost preliminary assay for identifying bioactive compounds.
- Artemia facilitates the screening and purification of potential therapeutic agents from plant sources.
Conclusions:
- Artemia salina serves as an effective bioassay for natural product research.
- The BSLA is instrumental in the early stages of drug discovery from medicinal plants.
- Further exploration of Artemia-based assays can accelerate the identification of novel bioactive compounds.

